Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 106

1.

1486PDPROGNOSTIC EVALUATION OF CLINICALLY STABLE FEBRILE NEUTROPENIA: PROSPECTIVE DATA FROM 921 PATIENTS FROM THE FINITE STUDY.

Fonseca PJ, Carmona-Bayonas A, Font C, Antonio Rebollo M, Ramchandani A, Hernando Cubero J, Espinosa J, De Castro EM, Ghanem I, Martínez J, Beato C, Virizuela J, Blasco A, Bonilla Y, Manzano A, Castañon E, Sevillano E, Vicente Conesa MA, De La Peña FA.

Ann Oncol. 2014 Sep 1;25(suppl_4):iv519. doi: 10.1093/annonc/mdu356.7. No abstract available.

PMID:
28171375
2.

A nomogram for predicting serious complications in patients with solid tumors and apparently stable febrile neutropenia: Prospective data on 781 consecutive episodes from the FINITE study.

Antonio Rebollo M, Garrido M, Martinez J, Font C, Ramchandani A, Biosca M, Beato C, Martinez de Castro E, Castanon E, Echaburu JV, Espinosa J, Sevillano E, Aragon Manrique I, Cardona M, Mondejar R, Baron F, Acevedo F, Jiménez-Fonseca P, Carmona Bayonas A.

J Clin Oncol. 2014 Nov;32(31_suppl):165. doi: 10.1200/jco.2014.32.31_suppl.165.

PMID:
28142683
3.

The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism.

Jiménez-Fonseca P, Carmona-Bayonas A, Font C, Plasencia-Martínez J, Calvo-Temprano D, Otero R, Beato C, Biosca M, Sánchez M, Benegas M, Varona D, Faez L, Antonio M, de la Haba I, Madridano O, Solis MP, Ramchandani A, Castañón E, Marchena PJ, Martín M, de la Peña FA, Vicente V; EPIPHANY study investigators and the Asociación de Investigación de la Enfermedad Tromboembólica de la Región de Murcia.

Clin Transl Oncol. 2017 Jul 10. doi: 10.1007/s12094-017-1713-3. [Epub ahead of print]

PMID:
28695478
4.

Sex Differences in Patients With Occult Cancer After Venous Thromboembolism.

Jara-Palomares L, Otero R, Jiménez D, Praena-Fernández JM, Rivas A, Font C, Wells PS, López-Reyes R, González-Martínez J, Monreal M.

Clin Appl Thromb Hemost. 2017 Jan 1:1076029617711805. doi: 10.1177/1076029617711805. [Epub ahead of print]

PMID:
28681634
5.

Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry.

Alatri A, Mazzolai L, Font C, Tafur A, Valle R, Marchena PJ, Ballaz A, Tiraferri E, Font L, Monreal M, Riete Investigators T.

Thromb Haemost. 2017 Jul 26;117(8):1630-1636. doi: 10.1160/TH17-02-0116. Epub 2017 May 18.

PMID:
28517021
6.

Venous thromboembolism in radiation therapy cancer patients: Findings from the RIETE registry.

Guy JB, Bertoletti L, Magné N, Rancoule C, Mahé I, Font C, Sanz O, Martín-Antorán JM, Pace F, Vela JR, Monreal M; RIETE investigators.

Crit Rev Oncol Hematol. 2017 May;113:83-89. doi: 10.1016/j.critrevonc.2017.03.006. Epub 2017 Mar 9. Review.

PMID:
28427527
7.

Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer.

Fernandez-Martinez A, Pascual T, Perrone G, Morales S, de la Haba J, González-Rivera M, Galván P, Zalfa F, Amato M, Gonzalez L, Prats M, Rojo F, Manso L, Paré L, Alonso I, Albanell J, Vivancos A, González A, Matito J, González S, Fernandez P, Adamo B, Muñoz M, Viladot M, Font C, Aya F, Vidal M, Caballero R, Carrasco E, Altomare V, Tonini G, Prat A, Martin M.

Oncotarget. 2017 Mar 28;8(13):21930-21937. doi: 10.18632/oncotarget.15748.

8.

Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index.

Carmona-Bayonas A, Jiménez-Fonseca P, Font C, Fenoy F, Otero R, Beato C, Plasencia JM, Biosca M, Sánchez M, Benegas M, Calvo-Temprano D, Varona D, Faez L, de la Haba I, Antonio M, Madridano O, Solis MP, Ramchandani A, Castañón E, Marchena PJ, Martín M, Ayala de la Peña F, Vicente V.

Br J Cancer. 2017 Apr 11;116(8):994-1001. doi: 10.1038/bjc.2017.48. Epub 2017 Mar 7.

PMID:
28267709
9.

FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence.

Jimenez-Fonseca P, Carmona-Bayonas A, Calderon C, Fontcuberta Boj J, Font C, Lecumberri R, Monreal M, Muñoz Martín AJ, Otero R, Rubio A, Ruiz-Artacho P, Suarez Fernández C, Colome E, Pérez Segura P.

Clin Transl Oncol. 2017 Aug;19(8):997-1009. doi: 10.1007/s12094-017-1632-3. Epub 2017 Feb 27.

PMID:
28243988
10.

Analysis of clinical factors affecting the rates of fatal pulmonary embolism and bleeding in cancer patients with venous thromboembolism.

Trujillo-Santos J, Martos FM, Font C, Farge-Bancel D, Rosa V, Lorenzo A, Barrón M, Lorente MA, Pedrajas JM, Monreal M.

Heliyon. 2017 Jan 16;3(1):e00229. doi: 10.1016/j.heliyon.2016.e00229. eCollection 2017 Jan.

11.

Prognostic value of computed tomography pulmonary angiography indices in patients with cancer-related pulmonary embolism: Data from a multicenter cohort study.

Plasencia-Martínez JM, Carmona-Bayonas A, Calvo-Temprano D, Jiménez-Fonseca P, Fenoy F, Benegas M, Sánchez M, Font C, Varona D, Martínez de la Haza D, Pueyo J, Biosca M, Antonio M, Beato C, Solís P, Fáez L, de Al Haba I, Hernández-Muñiz S, Madridano O, Martín M, Castañón E, Ramchandani A, Marchena P, Sánchez-Cánovas M, Vicente MÁ, Martínez MJ, Fernández-Plaza Á, Martínez-Encarnación L, Puerta A, Domínguez Á, Rodríguez D, Marín G, Otero R, Sánchez-Lasheras F, Vicente V.

Eur J Radiol. 2017 Feb;87:66-75. doi: 10.1016/j.ejrad.2016.12.010. Epub 2016 Dec 13.

PMID:
28065377
12.

Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study.

Font C, Carmona-Bayonas A, Beato C, Reig Ò, Sáez A, Jiménez-Fonseca P, Plasencia JM, Calvo-Temprano D, Sanchez M, Benegas M, Biosca M, Varona D, Vicente MA, Faez L, Solís MD, de la Haba I, Antonio M, Madridano O, Castañon E, Martinez MJ, Marchena P, Ramchandani A, Dominguez A, Puerta A, Martinez de la Haza D, Pueyo J, Hernandez S, Fernandez-Plaza A, Martinez-Encarnacion L, Martin M, Marin G, Ayala F, Vicente V, Otero R; Asociación para la Investigación de la Enfermedad Tromboembólica de la región de Murcia.

Eur Respir J. 2017 Jan 4;49(1). pii: 1600282. doi: 10.1183/13993003.00282-2016. Print 2017 Jan.

PMID:
28052954
13.

Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism.

Barrios D, Chavant J, Jiménez D, Bertoletti L, Rosa-Salazar V, Muriel A, Viallon A, Fernández-Capitán C, Yusen RD, Monreal M; Registro Informatizado de la Enfermedad TromboEmbólica Investigators.

Am J Med. 2017 May;130(5):588-595. doi: 10.1016/j.amjmed.2016.11.027. Epub 2016 Dec 21.

PMID:
28011316
14.

Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry.

Newton DH, Monreal Bosch M, Amendola M, Wolfe L, Perez Ductor C, Lecumberri R, Levy MM; RIETE Investigators.

J Vasc Surg Venous Lymphat Disord. 2017 Jan;5(1):18-24.e1. doi: 10.1016/j.jvsv.2016.08.002. Epub 2016 Oct 27.

PMID:
27987605
15.

Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.

Tzoran I, Papadakis M, Brenner B, Fidalgo Á, Rivas A, Wells PS, Gavín O, Adarraga MD, Moustafa F, Monreal M; Registro Informatizado de Enfermedad TromboEmbólica Investigators.

Am J Med. 2017 Apr;130(4):482.e1-482.e9. doi: 10.1016/j.amjmed.2016.11.016. Epub 2016 Dec 14.

PMID:
27986523
16.

The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site.

Mahé I, Chidiac J, Bertoletti L, Font C, Trujillo-Santos J, Peris M, Pérez Ductor C, Nieto S, Grandone E, Monreal M; RIETE investigators.

Am J Med. 2017 Mar;130(3):337-347. doi: 10.1016/j.amjmed.2016.10.017. Epub 2016 Nov 22.

PMID:
27884650
17.

Vasculitic neuropathy induced by pembrolizumab.

Aya F, Ruiz-Esquide V, Viladot M, Font C, Prieto-González S, Prat A, Arance A.

Ann Oncol. 2017 Feb 1;28(2):433-434. doi: 10.1093/annonc/mdw613. No abstract available.

PMID:
27864214
18.

Development of a Risk Prediction Score for Occult Cancer in Patients With VTE.

Jara-Palomares L, Otero R, Jimenez D, Carrier M, Tzoran I, Brenner B, Margeli M, Praena-Fernandez JM, Grandone E, Monreal M; RIETE Investigators.

Chest. 2017 Mar;151(3):564-571. doi: 10.1016/j.chest.2016.10.025. Epub 2016 Nov 1.

PMID:
27815153
19.

Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism.

Peris M, Jiménez D, Maestre A, Font C, Tafur AJ, Mazzolai L, Xifre B, Skride A, Dentali F, Monreal M; RIETE Investigators.

Eur Respir J. 2016 Nov;48(5):1360-1368. doi: 10.1183/13993003.00779-2016. Epub 2016 Sep 22.

PMID:
27660517
20.

Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors.

Carmona-Bayonas A, Jiménez-Fonseca P, Virizuela J, Antonio M, Font C, Biosca M, Ramchandani A, Martinez-Garcia J, Hernando J, Espinosa J, de Castro EM, Ghanem I, Beato C, Blasco A, Garrido M, Mondéjar R, Arcusa MÁ, Aragón I, Manzano A, Sevillano E, Castañón E, Ayala F; Supportive Care Working Group of the Spanish Society of Medical Oncology (SEOM).

Clin Transl Oncol. 2017 Mar;19(3):386-395. doi: 10.1007/s12094-016-1540-y. Epub 2016 Aug 15.

PMID:
27525978

Supplemental Content

Loading ...
Support Center